日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型:中国滤泡性淋巴瘤研讨会的一项研究

Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Liu, Huanhuan; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Lin, Zhijuan; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing

Anti-PD-1 antibody combined with P-GEMOX chemotherapy versus P-GEMOX chemotherapy with or without autologous stem-cell transplantation for previously untreated advanced natural killer/T cell lymphoma: a retrospective cohort study

抗PD-1抗体联合P-GEMOX化疗与P-GEMOX化疗联合或不联合自体干细胞移植治疗既往未接受治疗的晚期自然杀伤/T细胞淋巴瘤:一项回顾性队列研究

Zou, Qihua; Cao, Yi; Wang, Liang; Li, Wuping; Yin, Qingsong; Wu, Yudan; Jing, Hongmei; Peng, Zhigang; Sun, Xiuhua; Rao, Jun; Chen, Ying; Zhang, Hongyu; Zeng, Dongfeng; Li, Bingzong; Zhao, Ying; Zhang, Xudong; Zhang, Yuchen; Gao, Yan; Bai, Bing; Xia, Yi; Fang, Yu; Chen, Zouxiang; Nie, Man; Fang, Xiaojie; Bai, Shenrui; Huang, Huiqiang; Cai, Qingqing; Cai, Jun

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

针对接受一线全身治疗后外周T细胞淋巴瘤患者的 JAK1 选择性抑制剂 golidocitinib 的 II 期多中心维持治疗研究 (JACKPOT26)

Wei, Juying; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Zhou, Keshu; Wu, Huijing; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Li, Wenyu; Lin, Li'e; Xiao, Qing; Wang, Erhua; Jing, Hongmei; Zheng, Meifang; Zhang, Hongyu; Gao, Yuhuan; Gao, Da; Chen, Lijia; Jin, Jie

A revised staging system for natural killer/T cell lymphoma incorporating skull base invasion and nasal/non-nasal subtype distinction

修订后的自然杀伤/T细胞淋巴瘤分期系统,纳入了颅底侵犯和鼻/非鼻亚型区分。

Cao, Yi; Zhang, Yuchen; Wang, Liang; Song, Yongping; Qi, Shunan; Cai, Peiqiang; Tao, Rong; Li, Zhihua; Shuang, Yuerong; Yin, Qingsong; Peng, Zhigang; Zhong, Liye; Sun, Xiuhua; Zhang, Hongyu; Zhao, Ying; Jing, Hongmei; Li, Bingzong; Zou, Qihua; Huang, Huiqiang; Gao, Yan; Xia, Yi; Nie, Man; Fang, Xiaojie; Gao, Xinna; Bai, Shenrui; Cai, Jun; Cai, Qingqing

Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study

Talquetamab(一种GPRC5D×CD3双特异性抗体)治疗中国复发/难治性多发性骨髓瘤患者的疗效和安全性:来自MonumentTAL-1 1/2期研究

An, Gang; Jin, Jie; Cai, Zhen; Jing, Hongmei; Fu, Chengcheng; He, Pengcheng; Xia, Zhongjun; Liu, Rui; Li, Liang; Gai, Xue; Zhang, Hong; Zhu, Dian; Luo, Xinchao; Sun, Binbin; Xu, Hongmei; Zhou, Longen; Campagna, Michela; Masterson, Tara J; Lau, Bonnie W; Renaud, Thomas; Heuck, Christoph; Singh, Indrajeet; Vishwamitra, Deeksha; Qiu, Lugui

Unique phylogenies and metabolic adaptations of novel lineage III and comammox Nitrospira species from deep-sea sediments

来自深海沉积物的新型谱系 III 和完全氨氧化硝化螺旋菌属物种的独特系统发育和代谢适应性

Chen, Guohao; Jing, Hongmei; Liu, Bolin; Zhang, Jiawei; Ou, Yafei; Liu, Wenxiao; Tian, Xinru; Wang, Ran; Yan, Jinlin; Mao, Tieqiang; Yang, Sai; Zheng, Yanling; Hou, Lijun; Dong, Hongpo

Genomics-based insights into the expanded diversity and adaptation strategies of hadal trench anammox bacteria

基于基因组学的见解揭示了深渊海沟厌氧氨氧化细菌的多样性扩展和适应策略

Xiao, Yao; Zhao, Rui; Zhao, Weishu; Wang, Pudi; Xiao, Xiang; Peng, Xiaotong; Jing, Hongmei

A novel immune model predicts the prognosis of mantle cell lymphoma

一种新型免疫模型可预测套细胞淋巴瘤的预后

Hao, Xiaoyu; Zhang, Yuqi; Qi, Wenxin; Zhu, Mingxia; Wang, Jing; Yang, Ping; Zhang, Weilong; Jing, Hongmei

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma

TP53突变异质性揭示套细胞淋巴瘤的不同预后

Liu, Shuozi; Zhou, Shaowei; Zhang, Weilong; Wang, Jing; Wang, Lingli; Li, Chunyuan; Chen, Yingtong; Qi, Wenxin; Yang, Ping; Jing, Hongmei

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients

单核细胞百分比和结外受累对经典型霍奇金淋巴瘤预后的影响:一项纳入547例中国患者的多中心真实世界研究

Wang, Lingli; Pi, Jinping; He, Xiaohui; Zhang, Wei; Liu, Hui; Bai, Jiefei; Zhao, Yu; Zhong, Kaili; Bao, Li; Gao, Shan; Li, Zhenling; Wu, Jingjing; Zhou, Hebing; Chen, Yingtong; Liu, Shuozi; Jing, Hongmei